Hepatic and Renal Function with Successful Long-term Support on a Continuous Flow Left Ventricular Assist Device
- 1 March 2014
- journal article
- clinical trial
- Published by Elsevier in Heart Lung and Circulation
- Vol. 23 (3) , 229-233
- https://doi.org/10.1016/j.hlc.2013.07.021
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination TherapyCirculation: Heart Failure, 2012
- Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and MortalityCirculation, 2010
- Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implantsThe Journal of Heart and Lung Transplantation, 2010
- Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist DeviceCirculation, 2009
- Renal Function After Implantation of Continuous Versus Pulsatile Flow Left Ventricular Assist DevicesThe Journal of Heart and Lung Transplantation, 2008
- End-organ Function in Patients on Long-term Circulatory Support With Continuous- or Pulsatile-flow Assist DevicesThe Journal of Heart and Lung Transplantation, 2007
- Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 monthsThe Annals of Thoracic Surgery, 2003
- Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assistThe Annals of Thoracic Surgery, 2003
- End-organ function during chronic nonpulsatile circulationThe Annals of Thoracic Surgery, 2002
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001